Skip to main content
logo
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
106.62
+1.08 (1.02%)
At close: Feb 6, 2026, 4:00 PM EST
107.16
+0.54 (0.51%)
After-hours: Feb 6, 2026, 7:49 PM EST

BioNTech SE Revenue

BioNTech SE had revenue of 1.52B EUR in the quarter ending September 30, 2025, with 22.02% growth. This brings the company's revenue in the last twelve months to 3.15B, up 3.70% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.

Revenue (ttm)
3.15B EUR
Revenue Growth
+3.70%
P/S Ratio
6.92
Revenue / Employee
465,520 EUR
Employees
6,772
Market Cap
26.75B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG4.97B
Incyte4.81B
Genmab3.85B
argenx SE3.68B
Alnylam Pharmaceuticals3.21B
Royalty Pharma2.35B
Moderna2.23B
Ionis Pharmaceuticals966.96M
Revenue Rankings

BNTX News

More News